Co-Chair: Thomas J. Lynch, Jr. MD (Director of the Yale Cancer Center; and Physician-in-Chief of the Smilow Cancer Hospital at Yale-New Haven.) The conference included several keynotes, including Mikael Dolsten, President of Global R&D at Pfizer, and Rick Klausner, formerly the Director of the National Cancer Institute. There was a special talk focused on the global health aspects of cancer from Julio Frenk, Dean of the Harvard School of Public Health. Also among the speakers, there was talk by Siddhartha Mukherjee, author of the Pulitzer Prize-winning “Emperor of All Maladies: A Biography of Cancer.” This far-reaching event, culminated in a performance of Aditi Brennan Kapil’s Agnes Under the Big Top.
SCHEDULE OF EVENTS
9:00 – 9:30 REGISTRATION
9:30 – 10:05 OPENING REMARKS
Introduction and talk David Scheer (Event Chair, Vice-Chair Long Wharf Theatre,
President, Scheer & Company)
Gordon Edelstein (Artistic Director, Long Wharf Theatre)
Tom Lynch (Event Co-Chair, Physician-in-Chief, Yale Smilow Cancer Hospital)
Bob Alpern (Dean, Yale Medical School)
10:10 – 11:00 CANCER OVERVIEW
Rick Klausner (The Column Group, former Director of the National Cancer Institute)
Richard Lifton (Chair, Department of Genetics, Yale School of Medicine)
Bruce Chabner (Director of Clinical Research, MGH Cancer Center)
Mark Fishman (President, Novartis Institute of Biomedical Research)
11:00 – 11:15 ARTISTIC INTERLUDE
11:20 – 11:45 WRITING A “BIOGRAPHY OF CANCER”
Siddhartha Mukherjee (Author of Emperor of All Maladies: A Biography of Cancer,
Medical Oncologist, Columbia)
11:50 – 12:25 FROM BIOLOGY TO TARGETS
Mikael Dolsten (Senior VP & President, Worldwide Research & Development, Pfizer)
Julian Adams (President of R&D, CSO, Infinity Pharmaceuticals)
Ira Mellman (VP, Research & Oncology, Genentech)
Richard Gaynor (Vice President for Clinical Development and Medical Affairs
Oncology Business Unit, Lilly)
12:25 – 1:10 LUNCH (lunch boxes continue to be available until 2 pm)
1:10 – 1:25 ARTISTIC INTERLUDE
1:25 – 2:15 FROM TARGET TO TREATMENT
Panel Discussion
Introduction by Jerry Zeldis (CEO, Celgene Global Health)
Moderated by Howard Hochster (Associate Director, Yale Comprehensive Cancer
Center for Clinical Research)
Renzo Canetta (VP, Clinical Development/Oncology, Bristol Myers-Squibb)
Glenn Begley (VP, Global Head of Hematology and Oncology Research, Amgen)
Chris Takimoto (VP, Translational Medicine Early Development, JNJ/Ortho Biotech)
Keith Flaherty (Director of Development Therapeutics Program, MGH Cancer
Center)
2:20 – 2:30 THE ROLE OF BIOLOGIC THERAPIES IN TACKLING CANCER
Hans-Peter Gerber (Senior Director, BioConjugate/Vascular Biology Group, Pfizer)
2:30 – 2:40 SURGICAL DEVICE TECHNOLOGY DEVELOPMENT FOR CANCER
TREATMENT
Bob DeSantis (VP, R&D EndoMechanical & Intelligent Devices, Covidien)
2:45 – 4:00 PATIENT ADVOCACY AND ACCESS
Panel Discussion
Moderated by Mark Faries (Associate Professor of Surgical Oncology, Yale School of Medicine)
Roz Meyer (Clinical Psychologist, Patient Advocate)
Shabnam Kazmi (VP, Oncology Patient Advocacy and Brand Management, Otsuka)
Felicia Knaul (Director, Harvard Global Equity Initiative, Associate Professor, Harvard Medical School)
Leonard Farber (Clinical Oncologist, Yale-Smilow Cancer Hospital)
Kevin Lokay (VP & Business Unit Head of Oncology, Boehringer-Ingelheim)
Ruth McCorkle (Professor of Nursing, Epidemiology & Public Health, Yale School of
Nursing)
Kirsten Anderson (Chief of Staff for Chief Medical Officer, Aetna)
4:00 – 4:10 BREAK (10 minutes)
4:10 – 4:45 GLOBAL HEALTH AND PREVENTION (30 minutes)
Dan DiMaio (Professor, Scientific Director, Yale Cancer Center)
Melinda Irwin (Director of Cancer Control & Prevention, Yale Cancer Center)
Felicia Knaul (Director, Harvard Global Equity Initiative, Associate Professor, Harvard Medical School)
4:45 – 5:00 ARTISTIC INTERLUDE
4:55 – 6:00 PATHWAYS TO INNOVATION
INNOVATION IN ONCOLOGY, A PHARMA PERSPECTIVE
Susan Galbraith (introduced by David Scheer) (VP, Oncology, AstraZeneca)
Panel Discussion (55 minutes)
Moderated by David Scheer
Julian Adams (President of R&D, Infinity Pharmaceuticals)
Rinko Ghosh (Sr VP and Chief Business Officer, Nektar Therapeutics)
Dan Dubin (Leerink Swann)
John Puziss (Director, Yale Office of Cooperative Research)
Kevin Mills (Assistant Professor, The Jackson Laboratory)
Chris McLeod (CEO, 454/Roche)
6:00 – 6:25 SPECIAL KEYNOTE: GLOBAL HEALTH OVERVIEW (25 minutes)
Julio Frenk (introduced by David Scheer) (Dean, Harvard School of Public Health,
formerly Senior Advisor to Gates Foundation, and Minister of Health for Mexico)
6:25 – 6:35 AWARD PRESENTATION/CLOSING REMARKS/TRANSITION TO
DINNER: David Scheer and Tom Lynch, with Bruce Chabner (10 minutes)
6:35 – 7:50 DINNER (75 minutes)
7:50 – 8:15 TRANSITION TO STAGE II, DESSERT IN LOBBY (25 minutes)
8:15 – 9:45 PERFORMANCE – “AGNES UNDER THE BIG TOP” (90 minutes)
9:45 – 11:00 POST–PERFORMANCE PANEL: PUTTING IT ALL TOGETHER (75
minutes)
Moderator Michael Fuchs (CEO Concourse Health, former Chairman of HBO)
Aditi Brennan Kapil (Playwright, Agnes Under the Big Top)
Gordon Edelstein (Artistic Director, Long Wharf Theatre)
Eric Ting (Associate Artistic Director, Long Wharf Theatre)
Sid Mukherjee (Author, Medical Oncologist, Columbia)